发明名称 |
Quantitative Assessment of Human T-Cell Repertoire Recovery After Allogeneic Hematopoietic Stem Cell Transplantation |
摘要 |
A method and an apparatus are provided for determining T-cell repertoire recovery after allo-HSCT or identifying patients at high risk of infection. Combination of 5′-RACE PCR with deep sequencing was used to quantify TCR diversity in 33 individuals using a single oligonucleotide pair. Analysis of duplicate blood samples revealed highly reproducible detection of expanded TCR clonotypes. After 6 months, recipients of cord blood grafts without anti-thymocyte globulin therapy approximated the TCR diversity of healthy subjects, whereas recipients of T-cell-depleted peripheral blood stem cell grafts had a 28-fold and 14-fold lower CD4+ and CD8+ T-cell diversity, respectively. After 12 months, these differences had leveled out for the CD4+, but not the CD8+ T-cell compartment. |
申请公布号 |
US2015167084(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201314412715 |
申请日期 |
2013.07.03 |
申请人 |
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH |
发明人 |
Pamer Eric G.;van Heijst Jeroen W. J.;Perales Miguel-Angel;Van den Brink Marcel R. M. |
分类号 |
C12Q1/68;C12Q1/70 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for determining T-cell receptor β clonotype diversity and frequency in a subject, comprising
a) obtaining a blood sample from the subject b) isolating CD4+ and CD8+ T-lymphocytes, or subsets of CD4+ and CD8+ T-lymphocytes c) extracting total RNA from the cells isolated in step b), d) generating cDNA from the total RNA, e) amplifying the cDNA, f) sequencing the amplified cDNA, g) identifying T-cell receptor β clonotypes in the cDNA sequences and quantifying the diversity of the clonotypes and the clonotype frequency of each clonotype in the sample. |
地址 |
New York NY US |